Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOsentan for Mild Pulmonary Vascular Disease in ASD Patients (BOMPA trial)
2010-020209-33Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bosentan in atrial septal defect (ASD) and pulmonary vascular disease (PVD) (2 arms), sponsored by UZ Leuven. Primary endpoint: Decrease in pulmonary vascular resistance. Started Apr 2010; status: completed.
02
Drugs
bosentan
03
Conditions
atrial septal defect (ASD)pulmonary vascular disease (PVD)
Beyond the preview
Go deeper on 2010-020209-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020209-33.